Long-term effects of tolvaptan in patients requiring recurrent hospitalization for heart failure

Although reports suggest that tolvaptan does not reduce survival or subsequent hospitalization rates in heart failure patients, its continuous use has shown good outcomes in some patients who cannot be effectively managed with high doses of loop diuretics. Therefore, we investigated the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Hayato, Ajioka, Masayoshi, Ishii, Hideki, Okumura, Takahiro, Murase, Yosuke, Osanai, Hiroyuki, Nakasima, Yoshihito, Asano, Hiroshi, Sakai, Kazuyoshi, Murohara, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574322/
https://www.ncbi.nlm.nih.gov/pubmed/26412881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574322/
https://www.ncbi.nlm.nih.gov/pubmed/26412881

Ejemplares similares